Science Explorer Back to mapMap
Discussion
Researcher · Régie Autonome Multi Services D'Agadir · Morocco

Fatima Ezzahra Rizkou

Fatima Ezzahra Rizkou publishes mostly in Pathology and Forensic Medicine, Surgery and Pulmonary and Respiratory Medicine, on topics such as Tumors and Oncological Cases, Sarcoma Diagnosis and Treatment and Hearing Loss and Rehabilitation.

ORCID 0000-0001-6684-1089 OpenAlex
World rank
#6,234,622
of 7,710,434 ranked researchers
Rank in Morocco
#8,875
of 14,526
Works
25
Citations
27
Citations per work
1.1
h-index
2
i10-index 1Top 99% in Pathology and Forensic Medicine
Fatima Ezzahra Rizkou

What does Fatima Ezzahra Rizkou research?

Fatima Ezzahra Rizkou's work is mostly in Medicine (56%), Neuroscience (6%).

Health Sciences: 14 works · 55.9% of their workMedicine: 14 works · 55.9% of their workPathology and Forensic Medicine: 4 works · 14.7% of their workSurgery: 4 works · 14.7% of their workPulmonary and Respiratory Medicine: 3 works · 11.8% of their workRheumatology: 2 works · 8.8% of their workOncology: 1 works · 5.9% of their workEverything else: 10 works · 38.2% of their workLife Sciences: 1 works · 5.9% of their workNeuroscience: 1 works · 5.9% of their workCognitive Neuroscience: 1 works · 5.9% of their workTHEIR WORKFatima EzzahraRizkou25works
Life Sciences6%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1455.9%
  2. Everything else1038.2%
    1. Neuroscience15.9%
  1. 1Pathology and Forensic Medicine15% of their works
  2. 2Surgery15% of their works
  3. 3Pulmonary and Respiratory Medicine12% of their works
  4. 4Rheumatology9% of their works
  5. 5Oncology6% of their works
  6. 6Cognitive Neuroscience6% of their works

Research topics

Which keywords describe Fatima Ezzahra Rizkou's research?

The keywords of their largest research topics: Prognostic Factors, Granular Cell Tumor, Hearing Loss, Immunohistochemical Assessment, Osteosarcoma, Soft Tissue Sarcoma, Cochlear Implants and Cognitive Decline.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors123 topics
  2. Granular Cell Tumor71 topic
  3. Hearing Loss72 topics
  4. Immunohistochemical Assessment71 topic
  5. Osteosarcoma61 topic
  6. Soft Tissue Sarcoma61 topic
  7. Cochlear Implants41 topic
  8. Cognitive Decline41 topic
  9. Adenoid Cystic Carcinoma31 topic
  10. Cochlear Neuropathy31 topic
  11. Desmoid Tumor31 topic
  12. Salivary Gland Tumors31 topic
  13. Solitary Fibrous Tumor31 topic
  14. Tinnitus31 topic
  15. Delirium21 topic
  16. Differentiated Thyroid Cancer21 topic
  17. Intensive Care Unit21 topic
  18. Thyroid Nodules21 topic

Where does Fatima Ezzahra Rizkou work?

Fatima Ezzahra Rizkou's main affiliation in the publication record is Régie Autonome Multi Services D'Agadir, Morocco.

How many publications and citations does Fatima Ezzahra Rizkou have?

OpenAlex counts 25 works and 27 citations for Fatima Ezzahra Rizkou, an h-index of 2, ranking #6,234,622 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Fatima Ezzahra Rizkou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.